RNXT
RenovoRx, Inc.Company with tickers: RNXT
Market Cap
$42.52M
Shares Outstanding
45,052,706
CIK
1574094
CUSIP
75989R107
Website
Visit website
Investor Relations
Investor relations
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-K/A | 2026-05-15 | 2025-12-31 | |
| 10-Q | 2026-05-14 | 2026-03-31 | |
| 8-K | 2026-05-14 | — | |
| DEF 14A | 2026-04-30 | — | |
| 8-K | 2026-03-30 | — | |
| 10-K | 2026-03-30 | 2025-12-31 | |
| 8-K | 2026-03-27 | — | |
| 8-K | 2026-03-23 | — | |
| 8-K | 2026-02-06 | — | |
| 8-K | 2026-01-02 | — | |
| 8-K | 2025-11-14 | — | |
| 8-K | 2025-11-13 | — | |
| 10-Q | 2025-11-13 | 2025-09-30 | |
| 8-K | 2025-08-14 | — | |
| 10-Q | 2025-08-14 | 2025-06-30 | |
| 8-K | 2025-06-25 | — | |
| 8-K | 2025-05-15 | — | |
| 10-Q | 2025-05-15 | 2025-03-31 | |
| DEF 14A | 2025-04-30 | — | |
| 8-K | 2025-04-01 | — | |
| 10-K | 2025-04-01 | 2024-12-31 | |
| 8-K | 2025-02-10 | — | |
| 8-K | 2024-11-14 | — | |
| 10-Q | 2024-11-13 | 2024-09-30 | |
| 8-K | 2024-09-25 | — | |
| 8-K | 2024-08-16 | — | |
| 10-Q | 2024-08-13 | 2024-06-30 | |
| 8-K | 2024-06-07 | — | |
| 10-Q | 2024-05-10 | 2024-03-31 | |
| 8-K | 2024-05-03 | — | |
| DEF 14A | 2024-04-30 | — | |
| 8-K | 2024-04-18 | — | |
| 8-K | 2024-04-16 | — | |
| 8-K | 2024-04-15 | — | |
| 8-K | 2024-04-09 | — | |
| 10-K | 2024-04-01 | 2023-12-31 | |
| 8-K | 2024-03-14 | — | |
| 8-K | 2024-02-23 | — | |
| 8-K | 2024-02-09 | — | |
| 8-K | 2024-01-29 | — | |
| 8-K | 2024-01-02 | — | |
| 8-K | 2023-12-18 | — | |
| DEF 14A | 2023-11-27 | — | |
| 8-K | 2023-11-14 | — | |
| 10-Q | 2023-11-13 | 2023-09-30 | |
| 8-K | 2023-11-06 | 2023-10-31 | |
| 8-K | 2023-09-11 | 2023-09-07 | |
| 8-K | 2023-08-25 | 2023-08-21 | |
| 8-K | 2023-08-17 | — | |
| 10-Q | 2023-08-16 | 2023-06-30 |
Showing 1–50 of 76 filings